IL7 and lung carcinoma: Conversely, Wang et al. found that IL-7 (20 μg/mL/kg) administered every two days to mice with lung cancer significantly stimulated the development of tumor by increasing the expression of cyclin D1 and phosphorylation of c-Fos/c-Jun signals [27].